💊🧠 Why do some people respond so strongly to GLP-1 weight-loss drugs… while others barely notice? 🧠💊

It’s a question I hear more and more from leaders navigating their own health journeys.

And new neuroscience is starting to provide a fascinating piece of the puzzle.

Recent research has mapped, for the first time, where GLP-1 (the hormone mimicked by drugs like semaglutide and liraglutide) is expressed in the brain… and the differences between males and females are striking.

🔬 The science

Using a high-resolution technique called RNAscope, researchers mapped GLP-1 expression across 25 regions of the brain, creating the first sex-specific atlas of this important metabolic hormone (Ryu et al., 2026).

What they found was remarkable.

• Females showed higher GLP-1 density in several hindbrain regions responsible for appetite regulation.

• Males showed greater expression in the olfactory bulb, the brain’s smell centre.

• Some areas involved in reward and motivation circuits showed expression in only one sex.

These differences may help explain something clinicians have observed for years:

👉 Women often experience greater appetite suppression and weight loss on GLP-1 medications than men.

The reason appears to be biological signal strength.

More GLP-1 “receptors” in appetite-control circuits means the satiety signal may be amplified.

But the story doesn’t stop with metabolism.

GLP-1 activity was also identified in brain regions involved in:

🧠 reward processing

🧠 motivation and behaviour

🧠 memory and neurodegeneration

Which is why these drugs are now being explored for addiction, depression, and even Alzheimer’s disease.

Still early days… but incredibly intriguing.

🧭 What this means in the real world

For leaders and high performers trying to improve their metabolic health, it’s an important reminder of something we emphasise constantly.

Biology is personal.

Two people can take the same intervention…follow the same programme…and see very different results.

Not because one is “trying harder” than the other… but because physiology is different.

Which is why sustainable health strategies always combine:

🥗 nutrition

🏃 movement

😴 sleep

🧠 behavioural change

💊 and, where appropriate, medical therapies

GLP-1 medications are powerful tools.

But like any tool, they work best when embedded inside a broader system of habits and support.

🌱 The bigger reflection

The more we learn about the brain and metabolism, the clearer something becomes…Health is rarely about willpower. It’s about biology, environment, and behaviour working together. And when leaders understand that… they stop blaming themselves and start building systems that actually support long-term performance.

That’s where real change begins.